Kah Keng Wong

12PUBLICATIONS
14CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Haematological tumoursTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 10, 2025
MAGE-A in triple-negative breast cancer: molecular biology, epigenetic targeting, and immunotherapy.

Nik Mohd Asri Nik Amirah Auni, Norhanani Mohd Redzwan, Faezahtul Arbaeyah Hussain

|Aug 19, 2025
Antibody-drug conjugates in breast cancer: From therapeutic and immune activation mechanisms to resistance prevention.

Nik Mohd Asri Nik Amirah Auni, Norhanani Mohd Redzwan, Maya Mazuwin Yahya

|Jun 27, 2021
COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.

Che Mohd Nasril Che Mohd Nassir, Sabarisah Hashim, Kah Keng Wong

|May 31, 2021
Older age and diclofenac are associated with increased risk of upper gastrointestinal bleeding in gout patients.

Wan Syamimee Wan Ghazali, Wan Mohd Khairul Bin Wan Zainudin, Nurul Khaiza Yahya

|Jun 07, 2020
DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications.

Kah Keng Wong

Pageof 2